Midatech Pharma Plc | CIK:0001643918 | 3

  • Filed: 4/24/2018
  • Entity registrant name: Midatech Pharma Plc (CIK: 0001643918)
  • Generator: Novaworks Software
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/0001214659-18-002960-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1643918/000121465918002960/mtph-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001643918
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory

    6 Finance income and expense

        

        2017     2016    

     2015

     
    Finance income     £’000       £’000       £’000  
                             
    Interest received on bank deposits     15       164       53  
    Gain on equity settled derivative financial liability     400       1,173       1,638  
    Total finance income     415       1,337       1,691  

     

    The gain on the equity settled derivative financial liability in 2017 has arisen due to the reduction in the share price and the lapsing of warrants and options as it did in 2016.

     

        2017     2016     2015  
    Finance expense     £’000       £’000       £’000  
                             
    Bank loans     18       16       2  
    Other loans     91       57       3  
    Arrangement Fees     57       -       -  
    Total finance expense     166       73       5